Interferon β neutralizing antibodies in multiple sclerosis: neutralizing activity and cross-reactivity with three different preparations-Reference-Cited by-同舟云学术

Interferon β neutralizing antibodies in multiple sclerosis: neutralizing activity and cross-reactivity with three different preparations

Published:2000-07 Issue:2 Volume:48 Page:95-100
ISSN:0162-3109
Container-title:Immunopharmacology
language:en
Short-container-title:Immunopharmacology

Author:

Bertolotto Antonio,Malucchi Simona,Milano Eva,Castello Anna,Capobianco Marco,Mutani Roberto

Publisher

Elsevier BV

Subject

Pharmacology

Reference17 articles.

1. Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-β1a;Antonelli;Journal of Interferon and Cytokine Research,1998

2. Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b;Antonelli;Journal of the Neurological Sciences,1999

3. Correlation of the appearance of anti-interferon antibodies during treatment and diminution of efficacy: summary of an international workshop on anti-interferon antibodiess;Arnason;Journal of Interferon and Cytokine Research,1998

4. Prevalence of neutralizing anti-interferon antibodies (NABs) in MS patients treated with three different commercial preparation;Bertolotto;Multiple Sclerosis,1999

5. Antibodies to beta-interferons in multiple sclerosis: can we neutralize the controversy?;Cross;Neurology,1998

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis;CNS Drugs;2022-05-19

2. Immunogenicity Challenges Associated with Subcutaneous Delivery of Therapeutic Proteins;BioDrugs;2021-02-01

3. Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority;Frontiers in Neurology;2019-07-16

4. Neutralizing Antibodies Against Interferon-Beta in Korean Patients with Multiple Sclerosis;Journal of Clinical Neurology;2018

5. Neutralizing Antibodies and Multiple Sclerosis in the Era of Disease Modifying Treatments;Neuroinflammation;2018